Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and genetic characterization of non-optimal triptan response among migraine patients.

Cephalalgia : an international journal of headache - 1 Jan 2026

Brenna Ettore, Ferro Matteo, Sumelahti Marja-Liisa, Cajuso Tatiana, Ganna Andrea, Rossi Jari, Tikkanen Emmi

Abstract excerpt

AimThis study aimed to identify risk factors associated with non-optimal triptan response among migraine patients, leveraging the unique combination of genetic and longitudinal data available in the FinnGen project.MethodsWe analyzed register data from 5351 consistent triptan users within the FinnGen project, focusing on patients who switched triptan medications at least once within a two-year period. We assessed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cohort Studies
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Longitudinal Studies

Share to Migraine Disorders

Share to Polymorphism, Single Nucleotide

Share to Risk Factors

Source

Identifiers

PMID: 41603368
DOI: 10.1177/03331024251414621

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and genetic characterization of non-optimal triptan response among migraine patients.PMID 41603368Read ↗

Genetic and Phenotypic Profiling of Triptan Users in a Swedish Cluster Headache Cohort.Semantic proximity Read ↗

Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy.Semantic proximity Read ↗

Pathways to the best fit of triptans for migraine patients.Semantic proximity Read ↗

Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine.Semantic proximity Read ↗

Association between response to triptans and response to erenumab: real-life dataSemantic proximity Read ↗

The influence of genetic constitution on migraine drug responses.Semantic proximity Read ↗

Bi-allelic and tri-allelic 5-HTTLPR polymorphisms and triptan non-response in cluster headache.Semantic proximity Read ↗

Molecular mechanisms of migraine: prospects for pharmacogenomics.Semantic proximity Read ↗

Migraine polygenic risk score associates with efficacy of migraine-specific drugsSemantic proximity Read ↗

The impact of genetic factors on the response to migraine therapy.Semantic proximity Read ↗

Negative predictors of clinical response to triptans in patients with migraine.Semantic proximity Read ↗

The serotonin transporter gene polymorphism STin2 VNTR confers an increased risk of inconsistent response to triptans in migraine patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.